ORAI1 and COVID-19: However, a UK Biobank study found that genetic variants within ORAI1 were not associated with severe COVID-19 (Shawer et al., 2022) consistent with observational analyses that found no association between calcium channel blocker use and COVID-19 outcomes (Alsagaff et al., 2021).